Search

everythinglearnresearchcommunity

for

Search:↓

Mice genetically modified to produce more CD109 in their skin had less inflammation and better healing with less scarring.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Enhancing immune response can improve cancer treatment effectiveness.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

OCT4 helps granulosa cell growth in early-stage follicles, and FSH increases OCT4 through specific pathways.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

Cells from a skin condition can create new hair follicles and similar growths in mice, and a specific treatment can reduce these effects.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Targeting Vδ1+T-cells may help treat alopecia areata.

Lower TGFß1 levels help stem cells become beige fat cells.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

CTCF protein is essential for skin and hair follicle development in mice.

Scientists found a new type of skin cell that could help with skin repair and these cells work better with a certain protein.

AD-derived keratinocytes effectively mimic inflammation in atopic dermatitis.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.

Wnt signaling controls whether hair follicle stem cells stay inactive or regenerate hair.

TCF/Lef1 activity is essential for proper skin cell development and renewal.

Tcf3 helps cells move and heal wounds by controlling lipocalin 2.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Tofacitinib is a promising treatment for children with rheumatic diseases.